Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level
Prediction of remission in medullary thyroid carcinoma (MTC) depends on histopathological information often unavailable before surgery. Simply requiring a venous blood sample, preoperative basal calcitonin levels may be a better indicator of remission. In this institutional series of 224 consecutive...
Gespeichert in:
| Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2005-04, Vol.90 (4), p.2029-2034 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2034 |
|---|---|
| container_issue | 4 |
| container_start_page | 2029 |
| container_title | The journal of clinical endocrinology and metabolism |
| container_volume | 90 |
| creator | Machens, Andreas Schneyer, Ulrich Holzhausen, Hans-Jürgen Dralle, Henning |
| description | Prediction of remission in medullary thyroid carcinoma (MTC) depends on histopathological information often unavailable before surgery. Simply requiring a venous blood sample, preoperative basal calcitonin levels may be a better indicator of remission. In this institutional series of 224 consecutive patients with MTC and elevated preoperative basal calcitonin levels, postoperative calcitonin levels normalized in 28 (62%) of 45 patients with node-negative MTC and in 18 (10%) of 177 patients with node-positive MTC. On multivariate analysis, preoperative basal calcitonin levels greater than 500 pg/ml best predicted the failure to achieve biochemical remission, followed by nodal metastasis and reoperative status. Cumulative rates of biochemical remission fell continuously with rising serum basal calcitonin in node-negative patients. Node-positive patients did not achieve biochemical remission when their preoperative basal calcitonin levels exceeded 3000 pg/ml. Nodal metastasis started emerging at basal calcitonin levels of 10–40 pg/ml (normal range, |
| doi_str_mv | 10.1210/jc.2004-1836 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67718758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67718758</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-8262d3d6cf16ea074be8dd49b8bfa6c95e76937fd48ab75bf51c1ae6ad1c2363</originalsourceid><addsrcrecordid>eNptkD1v2zAQhokgQeMm3TIHXJKpSkmKIqUxMdI2gIsWhYd2IqjjqaUhkw4pFci_Dw0byNLphnvu430IueLsjgvOPm3gTjAmK97W6oQseCebSvNOn5IFY4JXnRa_zsn7nDeMcSmb-h05542qpeZ6QX7_SDHvEKZM40B_4tbn7GOgPtBv6OZxtOmFrv--pOgdXdoEPsStpfcAMTkf_tAp0geb7ViaI_gphjK5wn84XpKzwY4ZPxzrBVl_flwvv1ar71-elverCqTSU9UKJVztFAxcoWVa9tg6J7u-7QeroGtQq67Wg5Ot7XXTDw0HblFZx0HUqr4gt4e1uxSfZ8yTKREAy-MB45yN0pq3umkL-PEAQkmcEw5ml_y2xDOcmb1JswGzN2n2Jgt-fdw791t0b_BRXQFujoDNYMch2QA-v3FKtVo0onD1gcPgIiQfcJcwZ7OJcwpFzP_PvwIpTY2F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67718758</pqid></control><display><type>article</type><title>Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Machens, Andreas ; Schneyer, Ulrich ; Holzhausen, Hans-Jürgen ; Dralle, Henning</creator><creatorcontrib>Machens, Andreas ; Schneyer, Ulrich ; Holzhausen, Hans-Jürgen ; Dralle, Henning</creatorcontrib><description>Prediction of remission in medullary thyroid carcinoma (MTC) depends on histopathological information often unavailable before surgery. Simply requiring a venous blood sample, preoperative basal calcitonin levels may be a better indicator of remission. In this institutional series of 224 consecutive patients with MTC and elevated preoperative basal calcitonin levels, postoperative calcitonin levels normalized in 28 (62%) of 45 patients with node-negative MTC and in 18 (10%) of 177 patients with node-positive MTC. On multivariate analysis, preoperative basal calcitonin levels greater than 500 pg/ml best predicted the failure to achieve biochemical remission, followed by nodal metastasis and reoperative status. Cumulative rates of biochemical remission fell continuously with rising serum basal calcitonin in node-negative patients. Node-positive patients did not achieve biochemical remission when their preoperative basal calcitonin levels exceeded 3000 pg/ml. Nodal metastasis started emerging at basal calcitonin levels of 10–40 pg/ml (normal range, <10 pg/ml). Distant metastasis and extrathyroidal growth began appearing in patients with node-positive MTC at basal calcitonin levels of 150–400 pg/ml. There were no differences between patients with sporadic and hereditary MTC after adjusting for multiple testing. Preoperative basal calcitonin levels may thus help individualize the extent of surgery and postoperative follow-up intervals for MTC.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2004-1836</identifier><identifier>PMID: 15634717</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adolescent ; Adult ; Biological and medical sciences ; Calcitonin - blood ; Carcinoma, Medullary - blood ; Carcinoma, Medullary - pathology ; Child ; Endocrinopathies ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Logistic Models ; Lymphatic Metastasis ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Thyroid Neoplasms - blood ; Thyroid Neoplasms - pathology ; Thyroid. Thyroid axis (diseases) ; Vertebrates: endocrinology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2005-04, Vol.90 (4), p.2029-2034</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-8262d3d6cf16ea074be8dd49b8bfa6c95e76937fd48ab75bf51c1ae6ad1c2363</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16687252$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15634717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Machens, Andreas</creatorcontrib><creatorcontrib>Schneyer, Ulrich</creatorcontrib><creatorcontrib>Holzhausen, Hans-Jürgen</creatorcontrib><creatorcontrib>Dralle, Henning</creatorcontrib><title>Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Prediction of remission in medullary thyroid carcinoma (MTC) depends on histopathological information often unavailable before surgery. Simply requiring a venous blood sample, preoperative basal calcitonin levels may be a better indicator of remission. In this institutional series of 224 consecutive patients with MTC and elevated preoperative basal calcitonin levels, postoperative calcitonin levels normalized in 28 (62%) of 45 patients with node-negative MTC and in 18 (10%) of 177 patients with node-positive MTC. On multivariate analysis, preoperative basal calcitonin levels greater than 500 pg/ml best predicted the failure to achieve biochemical remission, followed by nodal metastasis and reoperative status. Cumulative rates of biochemical remission fell continuously with rising serum basal calcitonin in node-negative patients. Node-positive patients did not achieve biochemical remission when their preoperative basal calcitonin levels exceeded 3000 pg/ml. Nodal metastasis started emerging at basal calcitonin levels of 10–40 pg/ml (normal range, <10 pg/ml). Distant metastasis and extrathyroidal growth began appearing in patients with node-positive MTC at basal calcitonin levels of 150–400 pg/ml. There were no differences between patients with sporadic and hereditary MTC after adjusting for multiple testing. Preoperative basal calcitonin levels may thus help individualize the extent of surgery and postoperative follow-up intervals for MTC.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Calcitonin - blood</subject><subject>Carcinoma, Medullary - blood</subject><subject>Carcinoma, Medullary - pathology</subject><subject>Child</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Thyroid Neoplasms - blood</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Thyroid. Thyroid axis (diseases)</subject><subject>Vertebrates: endocrinology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkD1v2zAQhokgQeMm3TIHXJKpSkmKIqUxMdI2gIsWhYd2IqjjqaUhkw4pFci_Dw0byNLphnvu430IueLsjgvOPm3gTjAmK97W6oQseCebSvNOn5IFY4JXnRa_zsn7nDeMcSmb-h05542qpeZ6QX7_SDHvEKZM40B_4tbn7GOgPtBv6OZxtOmFrv--pOgdXdoEPsStpfcAMTkf_tAp0geb7ViaI_gphjK5wn84XpKzwY4ZPxzrBVl_flwvv1ar71-elverCqTSU9UKJVztFAxcoWVa9tg6J7u-7QeroGtQq67Wg5Ot7XXTDw0HblFZx0HUqr4gt4e1uxSfZ8yTKREAy-MB45yN0pq3umkL-PEAQkmcEw5ml_y2xDOcmb1JswGzN2n2Jgt-fdw791t0b_BRXQFujoDNYMch2QA-v3FKtVo0onD1gcPgIiQfcJcwZ7OJcwpFzP_PvwIpTY2F</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Machens, Andreas</creator><creator>Schneyer, Ulrich</creator><creator>Holzhausen, Hans-Jürgen</creator><creator>Dralle, Henning</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level</title><author>Machens, Andreas ; Schneyer, Ulrich ; Holzhausen, Hans-Jürgen ; Dralle, Henning</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-8262d3d6cf16ea074be8dd49b8bfa6c95e76937fd48ab75bf51c1ae6ad1c2363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Calcitonin - blood</topic><topic>Carcinoma, Medullary - blood</topic><topic>Carcinoma, Medullary - pathology</topic><topic>Child</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Thyroid Neoplasms - blood</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Thyroid. Thyroid axis (diseases)</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Machens, Andreas</creatorcontrib><creatorcontrib>Schneyer, Ulrich</creatorcontrib><creatorcontrib>Holzhausen, Hans-Jürgen</creatorcontrib><creatorcontrib>Dralle, Henning</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Machens, Andreas</au><au>Schneyer, Ulrich</au><au>Holzhausen, Hans-Jürgen</au><au>Dralle, Henning</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>90</volume><issue>4</issue><spage>2029</spage><epage>2034</epage><pages>2029-2034</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Prediction of remission in medullary thyroid carcinoma (MTC) depends on histopathological information often unavailable before surgery. Simply requiring a venous blood sample, preoperative basal calcitonin levels may be a better indicator of remission. In this institutional series of 224 consecutive patients with MTC and elevated preoperative basal calcitonin levels, postoperative calcitonin levels normalized in 28 (62%) of 45 patients with node-negative MTC and in 18 (10%) of 177 patients with node-positive MTC. On multivariate analysis, preoperative basal calcitonin levels greater than 500 pg/ml best predicted the failure to achieve biochemical remission, followed by nodal metastasis and reoperative status. Cumulative rates of biochemical remission fell continuously with rising serum basal calcitonin in node-negative patients. Node-positive patients did not achieve biochemical remission when their preoperative basal calcitonin levels exceeded 3000 pg/ml. Nodal metastasis started emerging at basal calcitonin levels of 10–40 pg/ml (normal range, <10 pg/ml). Distant metastasis and extrathyroidal growth began appearing in patients with node-positive MTC at basal calcitonin levels of 150–400 pg/ml. There were no differences between patients with sporadic and hereditary MTC after adjusting for multiple testing. Preoperative basal calcitonin levels may thus help individualize the extent of surgery and postoperative follow-up intervals for MTC.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>15634717</pmid><doi>10.1210/jc.2004-1836</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0021-972X |
| ispartof | The journal of clinical endocrinology and metabolism, 2005-04, Vol.90 (4), p.2029-2034 |
| issn | 0021-972X 1945-7197 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67718758 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adolescent Adult Biological and medical sciences Calcitonin - blood Carcinoma, Medullary - blood Carcinoma, Medullary - pathology Child Endocrinopathies Female Fundamental and applied biological sciences. Psychology Humans Logistic Models Lymphatic Metastasis Male Medical sciences Middle Aged Multivariate Analysis Non tumoral diseases. Target tissue resistance. Benign neoplasms Thyroid Neoplasms - blood Thyroid Neoplasms - pathology Thyroid. Thyroid axis (diseases) Vertebrates: endocrinology |
| title | Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A49%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospects%20of%20Remission%20in%20Medullary%20Thyroid%20Carcinoma%20According%20to%20Basal%20Calcitonin%20Level&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Machens,%20Andreas&rft.date=2005-04-01&rft.volume=90&rft.issue=4&rft.spage=2029&rft.epage=2034&rft.pages=2029-2034&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2004-1836&rft_dat=%3Cproquest_cross%3E67718758%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67718758&rft_id=info:pmid/15634717&rfr_iscdi=true |